Selection Strategies and Practical Application of BRAF V600E-mutated Non-Small Cell Lung Carcinoma

CONCLUSION: BRAF V600E-mutated NSCLCs could be enriched with the application of clinicopathologic parameters, which are not perfect. Therefore, additional VE1 immunohistochemistry may be useful as a screening method.PMID:34844291 | DOI:10.4143/crt.2021.843

Source: Cell Research - November 29, 2021 Category: Cytology Authors: Inwoo Hwang Yoon-La Choi Hyunwoo Lee Soohyun Hwang Boram Lee Hobin Yang Chaithanya Chelakkot Joungho Han Source Type: research